Accelerating global access to life-saving vaccines.

We apply rigorous science to build knowledge and support for the value of vaccines.

IVAC Collaborates with Global Partners to Tackle Cervical Cancer
January 2023

Worldwide, cervical cancer is the fourth most common cancer among women, with an estimated 604,000 new cases and 342,000 cervical cancer-related deaths reported in 2020. Two types of HPV contribute to nearly 50% of high-grade cervical cancers, underscoring the need for continued prevention, screening, and education. Vaccination against HPV remains the primary prevention method globally; […]

Read More >
IVAC’s Vaccine Hesitancy Training Course Has a Successful Test Run in Uttar Pradesh, India 
January 2023

It is well-known that vaccines save lives, but their effectiveness continues to be undermined by rampant vaccine misinformation. Healthcare workers have voiced that they are not equipped with the right information or preparation to combat this often polarizing and sensitive topic. To address this need, IVAC researchers recently developed a training course aimed toward healthcare […]

Read More >
VIRA Chatbot Competition Awarded to Three U.S. Health Departments
December 2022

Health departments will use custom AI chatbots to address COVID-19 misinformation View original press release by NACCHO Washington, DC—The National Association of County and City Health Officials (NACCHO) has announced the first three winners of the VIRA X NACCHO competition. These selected health departments will receive a customized version of the Vaccine Information Resource Assistant […]

Read More >
Digital Tools

IVAC’s digital platforms contain downloadable vaccine introduction maps, messaging compendiums, advocacy guides, and more.

Where We Work

IVAC works with governments and major research institutions in 38 countries

[Where We Work - Map]